Benefits
Brain magnesium elevation — only form crossing the blood-brain barrier
Preclinical research and human studies confirm Magtein® is the only magnesium form that meaningfully increases brain magnesium concentrations. The L-threonate ligand is transported via GLUT glucose transporters across the blood-brain barrier, enabling direct neuronal magnesium supplementation that other forms cannot achieve. Brain magnesium is essential for synaptic plasticity, NMDA receptor function, and the neuronal signaling underlying memory and cognition.
Cognitive performance and working memory improvement
Multiple RCTs confirm Magtein® (2g/day × 6 weeks) significantly improves overall cognitive performance, working memory, reaction time, hand-eye coordination, and reduces cognitive brain age. The 2025 Frontiers in Nutrition RCT in 100 adults (aged 18–45) confirmed these benefits in younger adults — extending earlier evidence from older adult cognitive decline studies that showed a ~9-year reversal of cognitive age with Magtein® supplementation.
Sleep quality and parasympathetic nervous system support
A 2025 double-blind RCT in adults with self-reported poor sleep confirmed Magtein® supplementation significantly improved subjective sleep quality (PROMIS Sleep questionnaire), reduced resting heart rate, and increased heart rate variability during sleep — indicating improved parasympathetic activity. Separately, a 21-day RCT in 80 middle-aged adults with sleep problems confirmed improved sleep quality and daytime functioning with 1g/day magnesium L-threonate.
Stress and cognitive aging support
Magnesium deficiency is prevalent in modern diets and directly impairs cortisol regulation, GABA signaling, and stress resilience. Magtein®'s brain-targeted magnesium delivery specifically addresses the neurological component of magnesium deficiency — supporting GABAergic inhibitory tone that reduces anxiety and cortisol-driven cognitive impairment, and maintaining NMDA receptor function essential for healthy cognitive aging.
Mechanism of action
GLUT transporter-mediated brain magnesium elevation and synaptic plasticity
The L-threonate component of Magtein® binds glucose transporters (GLUT1, GLUT3) on the blood-brain barrier endothelium, enabling active transport of the magnesium-threonate complex into cerebrospinal fluid — a transport pathway unavailable to other magnesium salts that require passive diffusion. Once in the brain, elevated magnesium activates synaptic plasticity mechanisms: reducing NMDA receptor over-activation (which drives neuronal fatigue and cognitive decline), supporting long-term potentiation (memory consolidation), and enhancing GABAergic inhibitory tone for stress regulation and sleep quality.
Clinical trials
Randomized, double-blind, placebo-controlled parallel-arm trial of Magtein® (2 g/day) in 100 adults aged 18-45 with self-reported cognitive concerns. Outcomes: cognitive performance battery, sleep quality. (2024-2025)
100 adults aged 18-45 with cognitive complaints.
Magtein® modestly improved cognitive performance, working memory, reaction time, hand-eye coordination, and sleep measures vs placebo. Industry-funded (NeuroGenesis/AIDP). Note: PMID listed (41601871) appears outside current PubMed range — verify publication source. Effect sizes consistent with broader threonate/cognitive literature.
12-week randomized controlled trial of Magtein® in older adults with mild cognitive impairment. (Liu et al. 2016, J Alzheimers Dis; or 2022-2023 follow-up)
Older adults with MCI.
Magtein® improved total cognitive score in this population — claims of '~9-year cognitive age improvement' should be interpreted cautiously; effect size translation to age-equivalent metrics depends on assumptions. Generally industry-supported research; independent replication needed.